Blunted muscle vasodilatation during chemoreceptor stimulation in patients with heart failure

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 293, Issue 1, 2007, Pages

  Di Vanna, Andrea ^a   Braga, Ana Maria F W ^a   Laterza, Mateus C ^a   Ueno, Linda M ^a   Rondon, Maria Urbana P B ^a   Barretto, Antonio C P ^a   Middlekauff, Holly R ^b   Negrão, Carlos E ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chemoreflex sensitivity; Forearm blood flow; Sympathetic nerve activity

Indexed keywords

OXYGEN;

ADULT; AGED; ARTICLE; CHEMORECEPTOR REFLEX; CLINICAL ARTICLE; CONDUCTANCE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOREARM BLOOD FLOW; HEART FAILURE; HUMAN; HYPERCAPNIA; HYPOXIA; MALE; MUSCLE BLOOD FLOW; MUSCLE INNERVATION; NEUROGRAPHY; OXYGEN BREATHING; PLETHYSMOGRAPHY; PRIORITY JOURNAL; RECEPTOR UPREGULATION; STATISTICAL SIGNIFICANCE; SYMPATHETIC NERVE; VASODILATATION; VEIN OCCLUSION;

ADULT; AGED; BLOOD FLOW VELOCITY; CARDIAC OUTPUT, LOW; CHEMORECEPTORS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; SYMPATHETIC NERVOUS SYSTEM; VASODILATION;

EID: 34547116901     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00156.2007     Document Type: Article

References (29)

1. Andersen KM, Faber JE. Differential sensitivity of arteriolar alpha 1- and alpha 2-adrenoceptor constriction to metabolic inhibition during rat skeletal muscle contraction. Circ Res 69: 178-184, 1991.
2. Azevedo LF, Brum PC, Mattos KC, Junqueira CM, Rondon MU, Barretto AC, Negrao CE. Effects of losartan combined with exercise training in spontaneously hypertensive rats. Braz J Med Biol Res 36: 1595-1603, 2003.
3. Chua TP, Clark AL, Amadi AA, Coats AJS. Relation between chemorsensitivity and the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol 27: 650-657, 1996.
4. Chua TP, Ponikowski P, Webb-Peploe K, Harrington D, Anker S, Piepoli M, Coats AJS. Clinical characteristics of patients with an augmented peripheral chemoreflex in chronic heart failure. Eur Heart J 18: 480-487, 1997.
5. De Mattos LD, Gardenghi G, Rondon MU, Soufen HN, Tirone AP, Barretto AC, Brum PC, Middelekauff HR, Negrao CE. Impact of 6 months of therapy with caverdilol in muscle sympathetic nerve activity in heart failure patients. J Card Fail 10: 496-502, 2004.
6. Hirooka Y, Imaizumi T, Tagawa T, Shiramoto M, Endo T, Ando S, Takeshita A. Effects of L-arginine on impaired acetylcholine- induced and ischemic vasodilation of the forearm in patients with heart failure. Circulation 90: 658-668, 1994.
7. Javaheri S. A mechanism of central sleep apnea in patients with heart failure patients. N Engl J Med 341: 949-954, 1999.
8. Li YL, Li YF, Liu D, Cornish KG, Patel KP, Zucker IH, Channon KM, Schultz HD. Gene transfer of neuronal nitric oxide synthase to carotid body reverses enhanced chemoreceptor function in heart failure rabbits. Circulation 97: 260-267, 2005.
9. Liu JL, Zucker IH. Regulation of sympathetic nerve activity in heart failure-a role for nitric oxide and angiotensin II. Circ Res 84: 417-423, 1999.
10. Marshall JM. Peripheral chemorecptors and cardiovascular regulation. Physiol Rev 74: 543-594, 1994.
11. Narkiewicz K, Pesek CA, Van de Borne PJH, Kato M, Somers VK. Enhanced sympathetic and ventilatory responses to central chemoreflex activation in heart failure. Circulation 100: 262-267, 1999.
12. Narkiewicz K, Van de Borne PJH, Montano N, Hering D, Kara T, Somers VK. Sympathetic neural outflow and chemoreflex sensitivity are related to spontaneous breathing rate in normal men. Hypertension 47: 51-55, 2006.
13. Negrao CE, Hamilton MA, Foranow CG, Hage A, Moriguchi JD, Middlekauff HR. Impaired endothelium-mediated vasodilation is not the principal cause of vasoconstriction in hear failure. Am J Physiol Heart Circ Physiol 278: H168-H174, 2000.
14. Negrao CE, Rondon MU, Tinucci T, Alves MJ, Roveda F, Braga AM, Reis SF, Nastari L, Barretto AC, Krieger EM, Middlekauff HR. Abnormal neurovascular control during exercise is linked to heart failure severity. Am J Physiol Heart Circ Physiol 280: H1286-H1292, 2001.
15. Pliquett RU, Cornish KG, Peuler JD, Zucker IH. Simvastatin normalizes autonomic neural control in heart failure. Circulation 107: 2493-2498, 2003.
16. Ponikowski P, Chua TP, Piepoli M, Ondusova D, Harrington Anker S, Volterrani M, Columbo R, Mazzuero G, Giordano A, Coats AJS. Augmented peripheral chemosensitivity as a potential input to barereflex impariment and autonomic imballance in chronic heart failure. Circulation 96: 2586-2594, 1997.
17. Prabhakar NR, Kumar GK, Chang CH, Agani FH, Haxhiu MA. Nitric oxide in the sensory function of the carotid body. Brain Res 625: 16-22, 1993.
18. Roveda F, Middlekauff HR, Rondon MUPB, Reis SF, Souza M, Nastari L, Barretto ACP, Krieger EM, Negrão CE. The effects of exercise training on sympathetic neural activation in advanced heart failure: a randomized controlled trial. J Am Coll Cardiol 42: 854-860, 2003.
19. Santos AC, Alves MJ, Rondon MU, Barretto AC, Middleukauff HR, Negrao CE. Sympathetic activation restrains endothelium-mediated muscle vasodilatation in heart failure patients. Am J Physiol Heart Circ Physiol 289: H593-H599, 2005.
20. Schultz HD, Sun SY. Chemoreflex function in heart failure. Heart Fail Rev 5: 45-56, 2000.
21. Somers VK, Mark AL, Zavala DC, Abboud FM. Influence of ventilation and hypocapnia on sympathetic nerve responses to hypoxia in normal humans. J Appl Physiol 67: 2095-2100, 1989.
22. Somers VK, Mark AL, Zavala DC, Abboud FM. Contrasting effects of hypoxia and hypercapnia on ventilation and sympathetic activity in humans. J Appl Physiol 67: 2101-2106, 1989.
23. Sun SY, Wang W, Zucker IH, Schultz HD. Enhanced peripheral chemoreflex function in conscious rabbits with pacing-induced heart failure. J Appl Physiol 86: 1264-1272, 1999.
24. Sun SY, Wang W, Zucker IH, Schultz HD. Enhanced activity of carotid body chemoreceptors in rabbits with heart failure: role of nitric oxide. J Appl Physiol 86: 1273-1282, 1999.
25. Turini GA, Brunner HR, Gribic M, Waeber B, Gravas H. Improvement of chronic congestive heart-failure by oral captopril. Lancet 1: 1213-1215, 1979.
26. Ueno H, Asanoi H, Yamada K, Oda Y, Takagawa T, Hirai T, Nozawa T, Takashima S, Inoue H. Attenuated respiratory modulation of chemoreflex-mediated sympathoexcitation in patients with chronic heart failure. J Card Fail 10: 236-246, 2004.
27. Wang W, Ma R. Cardiac sympathetic afferent reflexes in heart failure. Heart Fail Rev 5: 57-71, 2000.
28. Wang W, Zhu GQ, Patel KP, Zucker IH. AT1 receptor mRNA antisense normalizes enhanced cardiac sympathetic afferent reflex in rats with heart failure (Abstract). FASEB J 16: A830, 2002.
29. Weisbrod CJ, Minson CT, Joyner MJ, Halliwill JR. Effects of regional phentolamine on hypoxic vasodilatation humans. J Physiol 537: 613-621, 2001.